CA
CombiGene AB (publ) Stock: price and insider trades · Sweden
ISIN SE0014036117SE·
CombiGene AB (publ): what insiders have been doing
Only a handful of insider records exist for CombiGene AB (publ), the last one from 30 November 2020, too few to describe a trend. These figures are compiled from regulatory filings published by Finansinspektionen. They describe what insiders did and are not a recommendation.
Insider Decl.
3
Thresholds
n/a
Buy Volume
n/a
n/a
Sell Volume
n/a
n/a
Financial data
· cache
Last declaration on 30 November 2020
Declarations3 total
- 150,000 shares@ SEK 0.50100.0% of flowAktieISIN SE0006504593FI:csv-5d40b9e2dbecfda09142
- 150,000 shares0TeckningsoptionISIN SE0014111316FI:csv-6fccabeabc4c3f85a38d
- 476,002 shares0TeckningsrättISIN SE0014036117FI:csv-44817e27ab8c10dd1ae0
3 of 3 declarations
About CombiGene AB (publ)
CombiGene AB (publ) is a Swedish biopharmaceutical company focused on developing gene therapies for the treatment of neurological diseases. It is listed on the Stockholm Stock Exchange under the symbol XSTO.
Recent ranked signals on the same market
Purchases our model currently ranks for the recommendations list.
All recommendations